FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
FDA grant to fund research advancing minority health equity through diverse clinical trials, data, and patient perspectives.
Funder: Food and Drug Administration
Due Dates: Forecasted (Estimated application due date not yet posted)
Funding Amounts: Up to $1,000,000 per award; minimum $250,000; 4 awards expected
Summary: Supports innovative research to advance minority health and health equity, focusing on diversity in clinical trials, equitable data, and patient perspectives.
Key Information: Clinical trials are not allowed; this is a forecasted opportunity—final details and deadlines pending.
Description
This funding opportunity from the FDA Office of Minority Health and Health Equity (OMHHE) aims to support innovative research projects that strengthen and advance minority health and health equity objectives. The program is designed to:
- Advance equity in clinical trials by supporting efforts to increase diversity among trial participants.
- Promote equitable data collection and analysis by increasing the availability of data on diverse groups, including but not limited to ethnicity, race, age, disability, and geography.
- Elevate equity of voices by enhancing understanding of diverse patient perspectives, preferences, and unmet needs.
The award is intended for projects that do not involve clinical trials but can have a significant impact on health equity through research, data, and community engagement.
